KIRKLAND, WASHINGTON - October 14, 1998 - Radiant Research
announces the addition of Elaine S. Waller as Vice President of Clinical
Operations and Pharmaceutical Affairs. Dr. Waller will be responsible for
the development of Radiant Research's clinical operations, sales and
marketing strategies and client relationship building efforts.
Dr. Waller has 14 years experience in clinical research and
pharmaceutical development. Most recently she served as Vice President of
North American Drug Regulatory Affairs for Hoechst Marion Roussel, Inc.,
where she was responsible for North American regulatory strategies for all
development projects and approved products. Previously she was Vice
President of U.S. Regulatory Affairs for Marion Merrell Dow, Inc. Dr.
Waller received her PharmD from the University of Missouri - Kansas City
and an MBA from Rockhurst College.
"Dr. Waller will help set strategic direction for Clinical
Operations, Business Development and Marketing," commented Michael K.
Lester, President and CEO of Radiant Research. "Dr. Waller
understands our clients extremely well. Her extensive background working
with sponsors will be a tremendous asset in developing and supporting our
exceptional client and site relationships."
###
About Radiant Research
Based near Seattle, Washington, Radiant Research (radiantresearch.com) is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant is comprised of more than 30 wholly-owned premier clinical research centers nationwide, employing over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.
| Contact: |
|
Michael K. Lester
Chief Executive Officer
RADIANT RESEARCH
(425) 468-6200 |
Pamela M. Spaniac
Chief Financial Officer
RADIANT RESEARCH
(425) 468-6200 |
